Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOUNT-EASE: Aspirin and Ischemic Conditioning in Moyamoya Disease
NCT07762547Not yet recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Jul 2026
- Primary completion
- Feb 2030
- Countries
- 1
01
Overview
Randomised, double-blind trial of aspirin in Moyamoya disease and moyamoya syndrome (4 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: The primary efficacy endpoint event at 1 year. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
aspirin
03
Conditions
Moyamoya diseasemoyamoya syndrome
Beyond the preview
Go deeper on NCT07762547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07762547.